Bridgeway Capital Management’s Clearside Biomedical CLSD Stock Holding History

Bridgeway Capital Management’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,667	Closed	-$164K	–	1213
2025 Q2	$164K	Sell	13,667 -3,333	-20%	-$41.4K	﹤0.01%	999
2025 Q1	$234K	Hold	17,000	–	–	0.01%	890
2024 Q4	$242K	Hold	17,000	–	–	0.01%	965
2024 Q3	$324K	Buy	17,000 +8,333	+96%	+$142K	0.01%	963
2024 Q2	$169K	Sell	8,667 -13	-0.1%	-$251	﹤0.01%	1083
2024 Q1	$199K	Sell	8,680 -3,027	-26%	-$65.2K	﹤0.01%	1110
2023 Q4	$205K	Hold	11,707	–	–	﹤0.01%	1131
2023 Q3	$153K	Sell	11,707 -6,933	-37%	-$105K	﹤0.01%	1145
2023 Q2	$313K	Sell	18,640 -800	-4%	-$13.8K	0.01%	1035
2023 Q1	$303K	Sell	19,440 -1,667	-8%	-$32.4K	0.01%	1005
2022 Q4	$355K	Hold	21,107	–	–	0.01%	958
2022 Q3	$358K	Hold	21,107	–	–	0.01%	982
2022 Q2	$465K	Hold	21,107	–	–	0.01%	895
2022 Q1	$725K	Hold	21,107	–	–	0.01%	856
2021 Q4	$871K	Hold	21,107	–	–	0.02%	816
2021 Q3	$1.9M	Hold	21,107	–	–	0.04%	638
2021 Q2	$1.54M	Buy	21,107 +2,667	+14%	+$124K	0.03%	718
2021 Q1	$683K	Buy	18,440 +6,173	+50%	+$310K	0.01%	1005
2020 Q4	$504K	Hold	12,267	–	–	0.01%	953
2020 Q3	$283K	Hold	12,267	–	–	0.01%	1093
2020 Q2	$346K	Buy	12,267 +6,267	+104%	+$185K	0.01%	986
2020 Q1	$153K	Hold	6,000	–	–	﹤0.01%	1122
2019 Q4	$261K	Hold	6,000	–	–	﹤0.01%	1151
2019 Q3	$57K	Hold	6,000	–	–	﹤0.01%	1269
2019 Q2	$87K	Hold	6,000	–	–	﹤0.01%	1254
2019 Q1	$124K	Sell	6,000 -3,280	-35%	-$65.1K	﹤0.01%	1264
2018 Q4	$149K	Hold	9,280	–	–	﹤0.01%	1256
2018 Q3	$856K	Buy	9,280 +4,333	+88%	+$515K	0.01%	952
2018 Q2	$793K	Sell	4,947 -2,526	-34%	-$426K	0.01%	966
2018 Q1	$1.2M	Hold	7,473	–	–	0.01%	786
2017 Q4	$785K	Hold	7,473	–	–	0.01%	937
2017 Q3	$980K	Hold	7,473	–	–	0.01%	850
2017 Q2	$1.02M	Buy	7,473 +4,140	+124%	+$497K	0.01%	818
2017 Q1	$397K	Buy	+3,333	New	+$393K	﹤0.01%	1131